Virtu Financial LLC Insmed Inc Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$22.46 - $29.47 $260,244 - $341,468	-11,587 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$24.17 - $36.01 $280,057 - $417,247	11,587 New	11,587 $330,000
Q1 2021 May 19, 2021	SELL	$32.28 - $44.3 $666,356 - $914,484	-20,643 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$31.45 - $40.54 $649,222 - $836,867	20,643 New	20,643 $687,000
Q2 2020 Aug 07, 2020	SELL	$14.11 - $29.42 $215,657 - $449,655	-15,284 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$16.12 - $24.98 $70,621 - $109,437	4,381 Added 40.18%	15,284 $365,000
Q3 2019 Nov 20, 2019	BUY	$15.49 - $25.78 $168,887 - $281,079	10,903 New	10,903 $192,000
Q1 2019 Apr 12, 2019	SELL	$13.91 - $31.15 $194,350 - $435,227	-13,972 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$11.6 - $18.7 $162,075 - $261,276	13,972 New	13,972 $183,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.